CrowdStrike Is in Talks to Buy Zscaler in What Would Rank Among Cybersecurity’s Biggest Deals, as Zscaler Jumps 18% After Hours and Investors Who Poured $59 Billion Into Stock Funds Face a Correction

CrowdStrike is in talks to buy Zscaler, Bloomberg and Reuters report, sending Zscaler up about 18% after hours and CrowdStrike down 8%, just as stocks slid into a correction after a week of heavy fund inflows.

Read more

Big Pharma Says AI Has Cut the Time to Find New Drug Candidates by Up to Half, as Novartis Trims Its Growth Goal and a Congressional Panel Warns Deals Like Pfizer’s $2.6 Billion Starna Pact Are Shifting the Pipeline to China

GSK, Novartis, Novo Nordisk, Sanofi and other drugmakers told Reuters AI has cut early discovery timelines by as much as half. It comes as Novartis lowers its growth target and a U.S. commission warns that early-stage licensing deals with Chinese biotechs are handing Beijing an edge.

Read more